Financial Regulation

Guesty's new integrated platform aims to solve the biggest headache for Australian and New Zealand property managers: complex trust accounting regulations.

As illegal trade costs MA billions, a new coalition of leaders, law enforcement, and businesses unites to combat organized crime and controversial state policies.

A new partnership in Pennsylvania highlights the rise of 'doctor-led' support organizations, a model reshaping the business of specialized dental care.

Aravo launches its Advantage service to fix a costly enterprise problem: third-party risk programs that stall and fail to deliver on their promise.

Amid fierce competition, Triangle Insights Group hires a seasoned expert to guide clients through the complex world of drug pricing and market access.

The world's largest prediction market is partnering with a controversial data giant to ensure integrity. But what is the price of a clean market?

Atlanta lawyer Anne Tyler Hall lands on Inc.'s prestigious list for saving companies millions and mastering complex employee benefits law.

With a fresh $17.3M, AI firm Sigma360 is escalating its fight against financial crime, tackling a $300B market with tech born from counterterrorism.

The new partnership aims to replace periodic audits with continuous, AI-driven trust, reshaping the GRC landscape for the modern enterprise.

ViruSure's new GMP-validated test using Oxford Nanopore sequencing promises to slash drug safety testing times, boosting supply chain resilience.

Swiss firm Novafjord launches AI-driven arbitrage tools, betting on technology to unlock low-risk returns amid Europe's modest economic recovery.

A new AI platform promises to solve the toxicology industry's capacity crisis, but can it win the trust of regulators and the scientists it’s meant to help?

The data governance firm launches its new 'agentic' platform, aiming to free enterprises from 'pilot purgatory' by unifying data, AI, and compliance.

Early access programs for a rare blindness therapy in France, Israel, and the US offer hope to patients and provide a crucial financial lifeline for the company.

With $336M in the bank and three autoimmune drugs advancing, Jade Biosciences lays out a fast-paced timeline for key clinical milestones in 2026 and 2027.

The Texas Association of Builders has updated its industry-standard contracts. Here’s what they mean for risk, affordability, and homeowner protection.

The firm's new ISO 42001 certification signals a major shift towards verifiable, trustworthy AI for the highly regulated life sciences industry.

Crypto exchange Platov.co adds Turkish, Moldovan, and Kazakh currencies, a strategic move into high-demand markets with complex regulatory landscapes.

A new survey reveals over half of Americans delay healthcare, creating a 'health debt' crisis fueled by cost fears and scheduling conflicts for younger generations.

The biotech firm accelerates a key trial but faces a partner loss, widening losses, and a CEO search, putting its promising siRNA pipeline at a crossroads.